Alnylam Q1 2025 slides: 28% revenue growth as AMVUTTRA drives TTR franchise expansion#Alnylam #slides #revenue #growth…
Tag: Alnylam
Alnylam Presents New Data from the HELIOS-B Phase 3 Study of Vutrisiran in Patients with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM) at the American College of Cardiology's Annual Scientific Sess
Alnylam Presents New Data from the HELIOS-B Phase 3 Study of Vutrisiran in Patients with ATTR…
Alnylam Pharmaceuticals Ready To Go With Its Next Blockbuster
Alnylam Pharmaceuticals Ready To Go With Its Next Blockbuster #Alnylam #Pharmaceuticals #Ready #Blockbuster